NCT02270931View on ClinicalTrials.gov

A Prospective Longitudinal Breast Cancer Study

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Breast Cancer
Interventions
DEVICE

CA 15-3 Assay

Physicians use the CA 15-3 test result to manage their patients

Trial Locations (3)

28402

New Hanover Regional Medical Center, Wilmington

33316

Broward Health Medical Center, Fort Lauderdale

33486

Jane Skelton, MD, Boca Raton

Sponsors
All Listed Sponsors
lead

Fujirebio Diagnostics, Inc.

INDUSTRY